Evidence map›Paper›PMID 25554384›Full record

ReviewReproductive toxicology (Elmsford, N.Y.)2015

Hypothesis: Activation of rapid signaling by environmental estrogens and epigenetic reprogramming in breast cancer.

Lindsey S Treviño, Quan Wang, Cheryl L Walker

Open access · greenAbstract readReview
In one paragraph

Review in Reproductive toxicology (Elmsford, N.Y.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Oestrogen Detoxification Ability of White Rot FungusJournal of fungi (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Risks and benefits related to alimentary exposure to xenoestrogens.Critical reviews in food science and nutrition · 2017
    Review
  15. Endocrine Disruptors Leading to Obesity and Related Diseases.International journal of environmental research and public health · 2017
    Review
  16. Review
  17. Metabolism disrupting chemicals and metabolic disorders.Reproductive toxicology (Elmsford, N.Y.) · 2017
    Review
  18. Review
  19. Methoxychlor and Vinclozolin Induce Rapid Changes in Intercellular and Intracellular Signaling in Liver Progenitor Cells.Toxicological sciences : an official journal of the Society of Toxicology · 2016
    Article
  20. Minireview: Epigenomic Plasticity and Vulnerability to EDC Exposures.Molecular endocrinology (Baltimore, Md.) · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Lindsey S TreviñoCenter for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX, United States.
Quan WangCenter for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX, United States.
Cheryl L WalkerCenter for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX, United States. Electronic address: cwalker@ibt.tamhsc.edu.
Texas A&M Health Science Center · USTexas A&M University System · US

Funding

ENVIRONMENTAL ESTROGENS AND UTERINE LEIOMYOMAR01ES008263 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WALKER, CHERYL L. · 1996 to 2012
$3.8M
TARGETED GENOMICS FACILITY COREP30ES023512 · NIEHS · TEXAS A&M AGRILIFE RESEARCH · PI DEUTZ, NICOLAAS E · 2014 to 2017
$3.3M
Epigenetic Programmers Targeted During Developmental ReprogrammingR01ES023206 · NIEHS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI BEDFORD, MARK T., MANCINI, MICHAEL A. · 2013 to 2016
$2.3M
Developmental Reprogramming of Prostate Carcinogenesis by BPARC2ES018789 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WALKER, CHERYL L. · 2009 to 2010
$1.9M
Reversing the Effects of Developmental ReprogrammingR21ES020055 · NIEHS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI WALKER, CHERYL L. · 2011 to 2012
$420k
NIEHS NIH HHS P30 ES023512NIEHS NIH HHS R01 ES008263NIEHS NIH HHS R01 ES008263-14NIEHS NIH HHS R01 ES023206NIEHS NIH HHS R21 ES020055NIEHS NIH HHS RC2 ES018789NIEHS NIH HHS RC2 ES018789-02
6 · The paper itself

Abstract

Environmental and lifestyle factors are considered significant components of the increasing breast cancer risk in the last 50 years. Specifically, exposure to environmental endocrine disrupting compounds is correlated with cancer susceptibility in a variety of tissues. In both human and rodent models, the exposure to ubiquitous environmental estrogens during early life has been shown to disrupt normal mammary development and cause permanent adverse effects. Recent studies indicate that environmental estrogens not only have the ability to disrupt estrogen receptor (ER) signaling, but can also reprogram the epigenome by altering DNA and histone methylation through rapid, nongenomic ER actions. We have observed xenoestrogen-mediated activation of several nongenomic signaling pathways and have identified a target for epigenetic reprogramming in MCF-7 breast cancer cells. These observations, in addition to data from the literature, support the hypothesis that activation of rapid signaling by environmental estrogens can lead to epigenetic reprogramming and contribute to the progression of breast cancer.

Indexed as

Age FactorsAnimalsBreast NeoplasmsCarcinogens, EnvironmentalCell Transformation, NeoplasticCellular ReprogrammingEndocrine DisruptorsEnvironmental ExposureEpigenesis, GeneticEstrogensFemaleGene Expression Regulation, NeoplasticHumansMCF-7 CellsRisk AssessmentRisk FactorsCarcinogens, EnvironmentalEndocrine DisruptorsEstrogensBreast cancerEnvironmental estrogensEpigeneticsHistone modifiers

Identifiers

PMID25554384
PMCPMC4563990
OpenAlexW1980247606

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.